| developmental process (GO:0032502) | 1.36 | 6 | RET, BDNF, EDN3, GDNF, ASCL1, PHOX2B |
| positive regulation of cell differentiation (GO:0045597) | 3.01 | 6 | RET, BDNF, EDN3, GDNF, ASCL1, PHOX2B |
| cellular process (GO:0009987) | 0.26 | 6 | RET, BDNF, EDN3, GDNF, ASCL1, PHOX2B |
| positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 6 | RET, BDNF, EDN3, GDNF, ASCL1, PHOX2B |
| anatomical structure development (GO:0048856) | 1.58 | 6 | RET, BDNF, EDN3, GDNF, ASCL1, PHOX2B |
| regulation of cellular process (GO:0050794) | 0.5 | 6 | RET, BDNF, EDN3, GDNF, ASCL1, PHOX2B |
| single-organism developmental process (GO:0044767) | 1.49 | 6 | RET, BDNF, EDN3, GDNF, ASCL1, PHOX2B |
| regulation of cell differentiation (GO:0045595) | 2.42 | 6 | RET, BDNF, EDN3, GDNF, ASCL1, PHOX2B |
| single-organism cellular process (GO:0044763) | 0.65 | 6 | RET, BDNF, EDN3, GDNF, ASCL1, PHOX2B |
| regulation of multicellular organismal process (GO:0051239) | 1.87 | 6 | RET, BDNF, EDN3, GDNF, ASCL1, PHOX2B |
| positive regulation of biological process (GO:0048518) | 1.2 | 6 | RET, BDNF, EDN3, GDNF, ASCL1, PHOX2B |
| biological regulation (GO:0065007) | 0.39 | 6 | RET, BDNF, EDN3, GDNF, ASCL1, PHOX2B |
| movement of cell or subcellular component (GO:0006928) | 2.61 | 6 | RET, BDNF, EDN3, GDNF, ASCL1, PHOX2B |
| regulation of biological process (GO:0050789) | 0.45 | 6 | RET, BDNF, EDN3, GDNF, ASCL1, PHOX2B |
| single-organism process (GO:0044699) | 0.48 | 6 | RET, BDNF, EDN3, GDNF, ASCL1, PHOX2B |
| positive regulation of cellular process (GO:0048522) | 1.3 | 6 | RET, BDNF, EDN3, GDNF, ASCL1, PHOX2B |
| positive regulation of metabolic process (GO:0009893) | 1.74 | 5 | PHOX2B, EDN3, ASCL1, RET, GDNF |
| regulation of metabolic process (GO:0019222) | 1.02 | 5 | EDN3, ASCL1, PHOX2B, GDNF, RET |
| positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 5 | EDN3, ASCL1, PHOX2B, GDNF, RET |
| regulation of response to stimulus (GO:0048583) | 1.54 | 5 | RET, EDN3, ASCL1, GDNF, BDNF |
| signal transduction (GO:0007165) | 1.28 | 5 | RET, EDN3, ASCL1, GDNF, BDNF |
| regulation of signaling (GO:0023051) | 1.72 | 5 | EDN3, ASCL1, GDNF, BDNF, RET |
| regulation of cell communication (GO:0010646) | 1.73 | 5 | EDN3, GDNF, ASCL1, RET, BDNF |
| regulation of primary metabolic process (GO:0080090) | 1.08 | 5 | EDN3, ASCL1, PHOX2B, GDNF, RET |
| positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 5 | EDN3, ASCL1, PHOX2B, GDNF, RET |
| regulation of signal transduction (GO:0009966) | 1.84 | 5 | EDN3, GDNF, ASCL1, RET, BDNF |
| cellular developmental process (GO:0048869) | 1.82 | 5 | EDN3, PHOX2B, ASCL1, RET, GDNF |
| regulation of cell development (GO:0060284) | 3.01 | 5 | PHOX2B, ASCL1, GDNF, BDNF, RET |
| regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 5 | PHOX2B, EDN3, ASCL1, RET, GDNF |
| positive regulation of cell development (GO:0010720) | 3.57 | 5 | PHOX2B, ASCL1, GDNF, BDNF, RET |
| cell migration (GO:0016477) | 3.12 | 5 | PHOX2B, EDN3, ASCL1, RET, GDNF |
| regulation of gene expression (GO:0010468) | 1.37 | 5 | PHOX2B, EDN3, ASCL1, RET, GDNF |
| multicellular organismal process (GO:0032501) | 1.45 | 5 | EDN3, PHOX2B, ASCL1, RET, GDNF |
| regulation of developmental process (GO:0050793) | 2.1 | 5 | RET, PHOX2B, ASCL1, GDNF, BDNF |
| regulation of cellular metabolic process (GO:0031323) | 1.07 | 5 | EDN3, PHOX2B, ASCL1, RET, GDNF |
| locomotion (GO:0040011) | 2.91 | 5 | EDN3, ASCL1, PHOX2B, GDNF, RET |
| single-multicellular organism process (GO:0044707) | 1.78 | 5 | EDN3, ASCL1, PHOX2B, GDNF, RET |
| cell motility (GO:0048870) | 3.02 | 5 | PHOX2B, EDN3, ASCL1, RET, GDNF |
| positive regulation of developmental process (GO:0051094) | 2.77 | 5 | PHOX2B, GDNF, ASCL1, RET, BDNF |
| regulation of multicellular organismal development (GO:2000026) | 2.31 | 5 | PHOX2B, ASCL1, GDNF, BDNF, RET |
| system development (GO:0048731) | 2.92 | 5 | RET, PHOX2B, ASCL1, GDNF, BDNF |
| positive regulation of nucleic acid-templated transcription (GO:1903508) | 2.56 | 4 | PHOX2B, ASCL1, RET, GDNF |
| regulation of RNA metabolic process (GO:0051252) | 1.52 | 4 | RET, ASCL1, PHOX2B, GDNF |
| positive regulation of biosynthetic process (GO:0009891) | 2.29 | 4 | PHOX2B, ASCL1, RET, GDNF |
| regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 4 | RET, ASCL1, PHOX2B, GDNF |
| positive regulation of response to stimulus (GO:0048584) | 2.18 | 4 | EDN3, ASCL1, RET, BDNF |
| regulation of cellular component organization (GO:0051128) | 2.01 | 4 | EDN3, GDNF, RET, BDNF |
| positive regulation of signaling (GO:0023056) | 2.41 | 4 | EDN3, ASCL1, RET, BDNF |
| positive regulation of gene expression (GO:0010628) | 2.35 | 4 | PHOX2B, ASCL1, RET, GDNF |
| cell surface receptor signaling pathway (GO:0007166) | 2.09 | 4 | EDN3, ASCL1, RET, BDNF |
| ameboidal-type cell migration (GO:0001667) | 4.71 | 4 | EDN3, PHOX2B, GDNF, RET |
| regulation of cell death (GO:0010941) | 2.43 | 4 | RET, ASCL1, GDNF, BDNF |
| regulation of apoptotic process (GO:0042981) | 2.5 | 4 | RET, ASCL1, GDNF, BDNF |
| positive regulation of cell communication (GO:0010647) | 2.41 | 4 | EDN3, ASCL1, RET, BDNF |
| cellular component organization or biogenesis (GO:0071840) | 1.22 | 4 | PHOX2B, GDNF, BDNF, RET |
| regulation of neurogenesis (GO:0050767) | 3.21 | 4 | PHOX2B, ASCL1, RET, BDNF |
| cellular macromolecule metabolic process (GO:0044260) | 0.93 | 4 | PHOX2B, ASCL1, RET, GDNF |
| organic substance metabolic process (GO:0071704) | 0.63 | 4 | PHOX2B, ASCL1, RET, GDNF |
| positive regulation of signal transduction (GO:0009967) | 2.5 | 4 | EDN3, ASCL1, RET, BDNF |
| positive regulation of cellular biosynthetic process (GO:0031328) | 2.3 | 4 | PHOX2B, ASCL1, RET, GDNF |
| regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 4 | PHOX2B, ASCL1, RET, GDNF |
| cellular component organization (GO:0016043) | 1.24 | 4 | PHOX2B, GDNF, BDNF, RET |
| positive regulation of neurogenesis (GO:0050769) | 3.77 | 4 | PHOX2B, ASCL1, RET, BDNF |
| regulation of neuron differentiation (GO:0045664) | 3.39 | 4 | RET, ASCL1, PHOX2B, BDNF |
| regulation of programmed cell death (GO:0043067) | 2.49 | 4 | RET, ASCL1, GDNF, BDNF |
| positive regulation of neuron differentiation (GO:0045666) | 3.98 | 4 | PHOX2B, ASCL1, RET, BDNF |
| negative regulation of biological process (GO:0048519) | 1.33 | 4 | PHOX2B, ASCL1, GDNF, BDNF |
| regulation of cell proliferation (GO:0042127) | 2.41 | 4 | EDN3, ASCL1, PHOX2B, GDNF |
| cell differentiation (GO:0030154) | 2.14 | 4 | PHOX2B, ASCL1, EDN3, RET |
| positive regulation of nucleobase-containing compound metabolic process (GO:0045935) | 2.35 | 4 | PHOX2B, ASCL1, RET, GDNF |
| neuron differentiation (GO:0030182) | 4.17 | 4 | EDN3, PHOX2B, ASCL1, RET |
| regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 4 | RET, ASCL1, PHOX2B, GDNF |
| regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 4 | RET, ASCL1, PHOX2B, GDNF |
| animal organ development (GO:0048513) | 2.53 | 4 | PHOX2B, ASCL1, RET, GDNF |
| regulation of biosynthetic process (GO:0009889) | 1.37 | 4 | RET, ASCL1, PHOX2B, GDNF |
| tissue development (GO:0009888) | 3.27 | 4 | PHOX2B, ASCL1, RET, GDNF |
| regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 4 | RET, ASCL1, PHOX2B, GDNF |
| positive regulation of transcription, DNA-templated (GO:0045893) | 2.56 | 4 | PHOX2B, ASCL1, RET, GDNF |
| metabolic process (GO:0008152) | 0.58 | 4 | PHOX2B, ASCL1, RET, GDNF |
| regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 4 | PHOX2B, ASCL1, RET, GDNF |
| neural crest cell migration (GO:0001755) | 5.76 | 4 | EDN3, PHOX2B, GDNF, RET |
| primary metabolic process (GO:0044238) | 0.69 | 4 | RET, ASCL1, PHOX2B, GDNF |
| nervous system development (GO:0007399) | 3.53 | 4 | RET, ASCL1, GDNF, BDNF |
| positive regulation of nitrogen compound metabolic process (GO:0051173) | 2.29 | 4 | PHOX2B, ASCL1, RET, GDNF |
| regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 4 | PHOX2B, ASCL1, RET, GDNF |
| positive regulation of RNA metabolic process (GO:0051254) | 2.51 | 4 | RET, ASCL1, PHOX2B, GDNF |
| cellular metabolic process (GO:0044237) | 0.69 | 4 | RET, ASCL1, PHOX2B, GDNF |
| macromolecule metabolic process (GO:0043170) | 0.83 | 4 | RET, ASCL1, PHOX2B, GDNF |
| positive regulation of RNA biosynthetic process (GO:1902680) | 2.54 | 4 | PHOX2B, ASCL1, RET, GDNF |
| positive regulation of nervous system development (GO:0051962) | 3.64 | 4 | RET, ASCL1, PHOX2B, BDNF |
| positive regulation of macromolecule biosynthetic process (GO:0010557) | 2.39 | 4 | RET, ASCL1, PHOX2B, GDNF |
| regulation of nervous system development (GO:0051960) | 3.1 | 4 | RET, ASCL1, PHOX2B, BDNF |
| positive regulation of cellular component organization (GO:0051130) | 2.68 | 4 | EDN3, GDNF, RET, BDNF |
| negative regulation of cellular process (GO:0048523) | 1.41 | 4 | PHOX2B, ASCL1, GDNF, BDNF |
| regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 4 | PHOX2B, ASCL1, RET, GDNF |
| regulation of cell morphogenesis (GO:0022604) | 3.4 | 3 | RET, GDNF, BDNF |
| regulation of anatomical structure morphogenesis (GO:0022603) | 2.79 | 3 | RET, GDNF, BDNF |
| enteric nervous system development (GO:0048484) | 7.33 | 3 | PHOX2B, RET, GDNF |
| regulation of neuron apoptotic process (GO:0043523) | 4.47 | 3 | ASCL1, GDNF, BDNF |
| intracellular signal transduction (GO:0035556) | 2.39 | 3 | EDN3, RET, GDNF |
| anatomical structure morphogenesis (GO:0009653) | 2.53 | 3 | PHOX2B, RET, GDNF |
| multicellular organism development (GO:0007275) | 2.54 | 3 | PHOX2B, ASCL1, EDN3 |
| positive regulation of catalytic activity (GO:0043085) | 2.4 | 3 | EDN3, RET, GDNF |
| cellular response to stimulus (GO:0051716) | 1.97 | 3 | RET, ASCL1, PHOX2B |
| positive regulation of cell cycle (GO:0045787) | 3.94 | 3 | EDN3, ASCL1, PHOX2B |
| negative regulation of apoptotic process (GO:0043066) | 3.04 | 3 | ASCL1, GDNF, BDNF |
| sympathetic nervous system development (GO:0048485) | 6.96 | 3 | PHOX2B, ASCL1, GDNF |
| positive regulation of molecular function (GO:0044093) | 2.23 | 3 | EDN3, RET, GDNF |
| regulation of molecular function (GO:0065009) | 1.78 | 3 | EDN3, RET, GDNF |
| regulation of biological quality (GO:0065008) | 1.68 | 3 | EDN3, RET, GDNF |
| negative regulation of programmed cell death (GO:0043069) | 3.02 | 3 | ASCL1, GDNF, BDNF |
| positive regulation of cell proliferation (GO:0008284) | 3.01 | 3 | EDN3, ASCL1, GDNF |
| negative regulation of cell death (GO:0060548) | 2.95 | 3 | ASCL1, GDNF, BDNF |
| regulation of catalytic activity (GO:0050790) | 1.97 | 3 | EDN3, RET, GDNF |
| regulation of cell morphogenesis involved in differentiation (GO:0010769) | 3.91 | 3 | RET, GDNF, BDNF |
| regulation of mitotic cell cycle (GO:0007346) | 3.71 | 3 | EDN3, ASCL1, PHOX2B |
| response to chemical (GO:0042221) | 1.98 | 3 | PHOX2B, ASCL1, RET |
| regulation of neuron death (GO:1901214) | 4.19 | 3 | ASCL1, GDNF, BDNF |
| regulation of localization (GO:0032879) | 1.94 | 3 | EDN3, RET, GDNF |
| response to organic substance (GO:0010033) | 2.2 | 3 | RET, ASCL1, PHOX2B |
| system process (GO:0003008) | 2.3 | 3 | EDN3, PHOX2B, GDNF |
| regulation of cell cycle (GO:0051726) | 2.93 | 3 | PHOX2B, ASCL1, EDN3 |
| response to stimulus (GO:0050896) | 1.22 | 3 | PHOX2B, ASCL1, RET |
| regulation of transcription from RNA polymerase II promoter (GO:0006357) | 2.24 | 3 | PHOX2B, ASCL1, GDNF |
| positive regulation of transcription from RNA polymerase II promoter (GO:0045944) | 2.81 | 3 | PHOX2B, ASCL1, GDNF |
| regulation of extrinsic apoptotic signaling pathway (GO:2001236) | 4.69 | 2 | RET, GDNF |
| regulation of phosphate metabolic process (GO:0019220) | 2.35 | 2 | EDN3, RET |
| regulation of secretion (GO:0051046) | 3.2 | 2 | EDN3, GDNF |
| regulation of apoptotic signaling pathway (GO:2001233) | 3.83 | 2 | RET, GDNF |
| regulation of transport (GO:0051049) | 2.24 | 2 | EDN3, GDNF |
| cell development (GO:0048468) | 3.28 | 2 | PHOX2B, ASCL1 |
| cell maturation (GO:0048469) | 4.98 | 2 | RET, ASCL1 |
| muscle system process (GO:0003012) | 4.18 | 2 | EDN3, GDNF |
| negative regulation of neuron apoptotic process (GO:0043524) | 4.82 | 2 | GDNF, BDNF |
| enzyme linked receptor protein signaling pathway (GO:0007167) | 3.24 | 2 | RET, BDNF |
| transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169) | 3.54 | 2 | RET, BDNF |
| organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 2 | PHOX2B, ASCL1 |
| regulation of cell projection organization (GO:0031344) | 3.38 | 2 | RET, BDNF |
| organic cyclic compound metabolic process (GO:1901360) | 1.26 | 2 | PHOX2B, ASCL1 |
| positive regulation of cell projection organization (GO:0031346) | 3.99 | 2 | RET, BDNF |
| single-organism metabolic process (GO:0044710) | 1.63 | 2 | RET, GDNF |
| positive regulation of secretion (GO:0051047) | 3.85 | 2 | EDN3, GDNF |
| MAPK cascade (GO:0000165) | 3.91 | 2 | RET, GDNF |
| response to growth factor (GO:0070848) | 4.14 | 2 | PHOX2B, ASCL1 |
| negative regulation of neuron differentiation (GO:0045665) | 4.45 | 2 | PHOX2B, ASCL1 |
| regulation of epithelial cell differentiation (GO:0030856) | 4.96 | 2 | ASCL1, GDNF |
| negative regulation of cell development (GO:0010721) | 4.02 | 2 | PHOX2B, ASCL1 |
| muscle contraction (GO:0006936) | 4.37 | 2 | EDN3, GDNF |
| positive regulation of transport (GO:0051050) | 2.9 | 2 | EDN3, GDNF |
| phasic smooth muscle contraction (GO:0014821) | 6.96 | 2 | EDN3, GDNF |
| smooth muscle contraction (GO:0006939) | 5.9 | 2 | EDN3, GDNF |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239) | 5.86 | 2 | RET, GDNF |
| positive regulation of neuron projection development (GO:0010976) | 4.26 | 2 | RET, BDNF |
| regulation of neuron projection development (GO:0010975) | 3.69 | 2 | RET, BDNF |
| noradrenergic neuron development (GO:0003358) | 8.63 | 2 | PHOX2B, ASCL1 |
| tube formation (GO:0035148) | 4.98 | 2 | RET, GDNF |
| heterocycle metabolic process (GO:0046483) | 1.31 | 2 | PHOX2B, ASCL1 |
| regulation of phosphorylation (GO:0042325) | 2.5 | 2 | EDN3, RET |
| single organism signaling (GO:0044700) | 3.25 | 2 | EDN3, BDNF |
| positive regulation of phosphorylation (GO:0042327) | 2.9 | 2 | EDN3, RET |
| protein metabolic process (GO:0019538) | 1.45 | 2 | RET, GDNF |
| immune system process (GO:0002376) | 2.29 | 2 | EDN3, RET |
| aromatic compound biosynthetic process (GO:0019438) | 1.7 | 2 | PHOX2B, ASCL1 |
| neuron development (GO:0048666) | 4.8 | 2 | PHOX2B, ASCL1 |
| cellular response to chemical stimulus (GO:0070887) | 2.57 | 2 | PHOX2B, RET |
| positive regulation of kidney development (GO:0090184) | 6.02 | 2 | RET, GDNF |
| response to retinoic acid (GO:0032526) | 5.02 | 2 | RET, ASCL1 |
| nitrogen compound metabolic process (GO:0006807) | 1.13 | 2 | PHOX2B, ASCL1 |
| neuron migration (GO:0001764) | 5.0 | 2 | PHOX2B, ASCL1 |
| autonomic nervous system development (GO:0048483) | 8.12 | 2 | PHOX2B, GDNF |
| developmental maturation (GO:0021700) | 4.7 | 2 | RET, ASCL1 |
| nucleic acid-templated transcription (GO:0097659) | 1.91 | 2 | PHOX2B, ASCL1 |
| cellular protein metabolic process (GO:0044267) | 1.63 | 2 | RET, GDNF |
| positive regulation of GTPase activity (GO:0043547) | 3.28 | 2 | RET, GDNF |
| positive regulation of hydrolase activity (GO:0051345) | 2.91 | 2 | RET, GDNF |
| regulation of anatomical structure size (GO:0090066) | 3.78 | 2 | EDN3, RET |
| signal transduction by protein phosphorylation (GO:0023014) | 3.79 | 2 | RET, GDNF |
| anatomical structure formation involved in morphogenesis (GO:0048646) | 3.01 | 2 | RET, GDNF |
| heterocycle biosynthetic process (GO:0018130) | 1.7 | 2 | PHOX2B, ASCL1 |
| positive regulation of cell migration (GO:0030335) | 3.77 | 2 | EDN3, RET |
| phosphorylation (GO:0016310) | 2.63 | 2 | RET, GDNF |
| macromolecule modification (GO:0043412) | 1.73 | 2 | RET, GDNF |
| protein modification process (GO:0036211) | 1.79 | 2 | RET, GDNF |
| nucleobase-containing compound biosynthetic process (GO:0034654) | 1.72 | 2 | PHOX2B, ASCL1 |
| negative regulation of neuron death (GO:1901215) | 4.57 | 2 | GDNF, BDNF |
| regulation of hydrolase activity (GO:0051336) | 2.53 | 2 | RET, GDNF |
| cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 2 | PHOX2B, ASCL1 |
| positive regulation of protein modification process (GO:0031401) | 2.7 | 2 | EDN3, RET |
| negative regulation of nervous system development (GO:0051961) | 4.15 | 2 | PHOX2B, ASCL1 |
| regulation of cell motility (GO:2000145) | 3.16 | 2 | EDN3, RET |
| transcription, DNA-templated (GO:0006351) | 1.91 | 2 | PHOX2B, ASCL1 |
| positive regulation of cell motility (GO:2000147) | 3.74 | 2 | EDN3, RET |
| RNA biosynthetic process (GO:0032774) | 1.84 | 2 | PHOX2B, ASCL1 |
| regulation of cell cycle process (GO:0010564) | 3.5 | 2 | EDN3, PHOX2B |
| kidney development (GO:0001822) | 4.79 | 2 | RET, GDNF |
| cellular biosynthetic process (GO:0044249) | 1.37 | 2 | PHOX2B, ASCL1 |
| cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 2 | PHOX2B, ASCL1 |
| signaling (GO:0023052) | 3.25 | 2 | EDN3, BDNF |
| regulation of secretion by cell (GO:1903530) | 3.28 | 2 | EDN3, GDNF |
| glial cell differentiation (GO:0010001) | 5.48 | 2 | PHOX2B, ASCL1 |
| positive regulation of secretion by cell (GO:1903532) | 3.93 | 2 | EDN3, GDNF |
| regulation of GTPase activity (GO:0043087) | 3.21 | 2 | RET, GDNF |
| response to endogenous stimulus (GO:0009719) | 2.79 | 2 | PHOX2B, ASCL1 |
| nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 2 | PHOX2B, ASCL1 |
| regulation of intracellular signal transduction (GO:1902531) | 2.31 | 2 | EDN3, RET |
| regulation of system process (GO:0044057) | 3.53 | 2 | EDN3, PHOX2B |
| positive regulation of phosphorus metabolic process (GO:0010562) | 2.78 | 2 | EDN3, RET |
| negative regulation of multicellular organismal process (GO:0051241) | 2.84 | 2 | PHOX2B, ASCL1 |
| regulation of protein metabolic process (GO:0051246) | 1.93 | 2 | EDN3, RET |
| positive regulation of protein metabolic process (GO:0051247) | 2.43 | 2 | EDN3, RET |
| negative regulation of neurogenesis (GO:0050768) | 4.22 | 2 | PHOX2B, ASCL1 |
| positive regulation of cellular protein metabolic process (GO:0032270) | 2.49 | 2 | EDN3, RET |
| regulation of protein modification process (GO:0031399) | 2.32 | 2 | EDN3, RET |
| central nervous system neuron differentiation (GO:0021953) | 5.17 | 2 | PHOX2B, ASCL1 |
| RNA metabolic process (GO:0016070) | 1.59 | 2 | PHOX2B, ASCL1 |
| epithelium development (GO:0060429) | 4.57 | 2 | RET, GDNF |
| cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 2 | PHOX2B, ASCL1 |
| regulation of kidney development (GO:0090183) | 5.72 | 2 | RET, GDNF |
| negative regulation of cell differentiation (GO:0045596) | 3.33 | 2 | PHOX2B, ASCL1 |
| cellular macromolecule biosynthetic process (GO:0034645) | 1.66 | 2 | PHOX2B, ASCL1 |
| regulation of locomotion (GO:0040012) | 3.12 | 2 | EDN3, RET |
| mesonephric tubule development (GO:0072164) | 5.82 | 2 | RET, GDNF |
| embryonic epithelial tube formation (GO:0001838) | 6.4 | 2 | RET, GDNF |
| metanephros development (GO:0001656) | 6.02 | 2 | RET, GDNF |
| ureteric bud development (GO:0001657) | 5.97 | 2 | RET, GDNF |
| negative regulation of developmental process (GO:0051093) | 3.17 | 2 | PHOX2B, ASCL1 |
| regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 2 | EDN3, RET |
| regulation of axonogenesis (GO:0050770) | 4.59 | 2 | RET, BDNF |
| positive regulation of metanephros development (GO:0072216) | 7.09 | 2 | RET, GDNF |
| epithelial tube formation (GO:0072175) | 6.36 | 2 | RET, GDNF |
| regulation of metanephros development (GO:0072215) | 6.59 | 2 | RET, GDNF |
| organic substance biosynthetic process (GO:1901576) | 1.34 | 2 | PHOX2B, ASCL1 |
| positive regulation of cell morphogenesis involved in differentiation (GO:0010770) | 4.65 | 2 | GDNF, BDNF |
| cell projection organization (GO:0030030) | 3.14 | 2 | PHOX2B, GDNF |
| nucleic acid metabolic process (GO:0090304) | 1.46 | 2 | PHOX2B, ASCL1 |
| leukocyte migration (GO:0050900) | 4.19 | 2 | EDN3, RET |
| positive regulation of cell death (GO:0010942) | 3.32 | 2 | RET, ASCL1 |
| kidney epithelium development (GO:0072073) | 5.54 | 2 | RET, GDNF |
| ganglion development (GO:0061548) | 7.16 | 2 | PHOX2B, ASCL1 |
| response to lipid (GO:0033993) | 3.11 | 2 | RET, ASCL1 |
| sympathetic ganglion development (GO:0061549) | 7.53 | 2 | PHOX2B, ASCL1 |
| cellular component morphogenesis (GO:0032989) | 3.5 | 2 | PHOX2B, GDNF |
| positive regulation of apoptotic process (GO:0043065) | 3.38 | 2 | RET, ASCL1 |
| cellular response to organic substance (GO:0071310) | 2.78 | 2 | PHOX2B, RET |
| tissue morphogenesis (GO:0048729) | 3.87 | 2 | RET, GDNF |
| positive regulation of programmed cell death (GO:0043068) | 3.38 | 2 | RET, ASCL1 |
| positive regulation of mitotic cell cycle (GO:0045931) | 4.98 | 2 | EDN3, PHOX2B |
| protein phosphorylation (GO:0006468) | 2.89 | 2 | RET, GDNF |
| regulation of cell migration (GO:0030334) | 3.23 | 2 | EDN3, RET |
| positive regulation of phosphate metabolic process (GO:0045937) | 2.78 | 2 | EDN3, RET |
| positive regulation of cell cycle process (GO:0090068) | 4.25 | 2 | EDN3, PHOX2B |
| cellular protein modification process (GO:0006464) | 1.79 | 2 | RET, GDNF |
| regulation of phosphorus metabolic process (GO:0051174) | 2.35 | 2 | EDN3, RET |
| biosynthetic process (GO:0009058) | 1.32 | 2 | PHOX2B, ASCL1 |
| macromolecule biosynthetic process (GO:0009059) | 1.61 | 2 | PHOX2B, ASCL1 |
| cell-cell signaling (GO:0007267) | 3.35 | 2 | EDN3, BDNF |
| cell communication (GO:0007154) | 3.04 | 2 | EDN3, BDNF |
| tube development (GO:0035295) | 4.41 | 2 | RET, GDNF |
| response to oxygen-containing compound (GO:1901700) | 2.57 | 2 | RET, ASCL1 |
| positive regulation of cellular component movement (GO:0051272) | 3.71 | 2 | EDN3, RET |
| regulation of cellular component movement (GO:0051270) | 3.08 | 2 | EDN3, RET |
| positive regulation of locomotion (GO:0040017) | 3.71 | 2 | EDN3, RET |
| phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 2 | RET, GDNF |
| mesonephric epithelium development (GO:0072163) | 5.8 | 2 | RET, GDNF |
| phosphorus metabolic process (GO:0006793) | 2.15 | 2 | RET, GDNF |
| regulation of protein phosphorylation (GO:0001932) | 2.57 | 2 | EDN3, RET |
| positive regulation of protein phosphorylation (GO:0001934) | 2.95 | 2 | EDN3, RET |
| response to acid chemical (GO:0001101) | 4.05 | 2 | RET, ASCL1 |